Cargando…

SARS-CoV-2 reinfection: Adding insult to dysfunctional endothelium in patients with atherosclerotic cardiovascular disease

In this short narrative review, we aim at defining the pathophysiological role endothelial dysfunction in the observed COVID-19–associated rise in risk of cardiovascular disease. Variants of the SARS-CoV-2 virus have caused several epidemic waves of COVID-19, and the emergence and rapid spread of ne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kovanen, Petri T., Vuorio, Alpo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238112/ https://www.ncbi.nlm.nih.gov/pubmed/37293388 http://dx.doi.org/10.1016/j.athplu.2023.06.002

Ejemplares similares

Prevention of endothelial dysfunction and thrombotic events in COVID-19 patients with familial hypercholesterolemia
por: Vuorio, Alpo, et al.
Publicado: (2020)

Opportunities for preventing further endothelial dysfunction in pregnant COVID-19 patients with familial hypercholesterolemia
por: Vuorio, Alpo, et al.
Publicado: (2022)

Wildfire smoke exposure and cardiovascular disease—should statins be recommended to prevent cardiovascular events?
por: Vuorio, Alpo, et al.
Publicado: (2023)

Coronary microcirculatory dysfunction in hypercholesterolemic patients with COVID-19: potential benefit from cholesterol-lowering treatment
por: Vuorio, Alpo, et al.
Publicado: (2023)

Decreasing the Cholesterol Burden in Heterozygous Familial Hypercholesterolemia Children by Dietary Plant Stanol Esters
por: Vuorio, Alpo, et al.
Publicado: (2018)

Mucormycosis and glucose‐regulated protein 78 in COVID‐19: Amenable to statin treatment?
por: Vuorio, Alpo, et al.
Publicado: (2021)

Statins as Adjuvant Therapy for COVID-19 to Calm the Stormy Immunothrombosis and Beyond
por: Vuorio, Alpo, et al.
Publicado: (2021)

Comment on: “Prior Treatment with Statins is Associated with Improved Outcomes of Patients with COVID-19: Data from the SEMI-COVID-19 Registry”
por: Vuorio, Alpo, et al.
Publicado: (2021)

Familial hypercholesterolaemia and COVID-19: A two-hit scenario for endothelial dysfunction amenable to treatment
por: Vuorio, Alpo, et al.
Publicado: (2021)

Prevention of Cardiovascular Burden in COVID-19 Patients Suffering from Familial Hypercholesterolemia: A Global Challenge
por: Vuorio, Alpo, et al.
Publicado: (2021)

Long-Term Cardiovascular and Cerebrovascular Challenges Posed by COVID-19 in Patients With Familial Hypercholesterolemia
por: Vuorio, Alpo, et al.
Publicado: (2022)

Hypercholesterolemia and COVID-19: Statins for Lowering the Risk of Venous Thromboembolism
por: Vuorio, Alpo, et al.
Publicado: (2021)

Familial hypercholesterolemia and statins in the COVID-19 era: Mitigating the risk of ischemic stroke
por: Vuorio, Alpo, et al.
Publicado: (2021)

Hospitalized Children With Familial Hypercholesterolemia and COVID-19: A Case for Preventive Anticoagulation
por: Vuorio, Alpo, et al.
Publicado: (2021)

Elevated Lipoprotein(a) and Cerebral Venous Sinus Thrombosis in COVID-19
por: Vuorio, Alpo, et al.
Publicado: (2021)

Patients with familial hypercholesterolemia and COVID-19: Efficient and ongoing cholesterol lowering is paramount for the prevention of acute myocardial infarction
por: Kovanen, Petri T., et al.
Publicado: (2021)

Monkeypox is a global public health emergency: The role of repurposing cholesterol lowering drugs not to be forgotten
por: Vuorio, Alpo, et al.
Publicado: (2022)

Continuation of fibrate therapy in patients with metabolic syndrome and COVID-19: a beneficial regime worth pursuing
por: Vuorio, Alpo, et al.
Publicado: (2022)

Cholesterol-lowering drugs for high-risk hypercholesterolemia patients with COVID-19 while on Paxlovid™ therapy
por: Vuorio, Alpo, et al.
Publicado: (2022)

Drug-drug interaction with oral antivirals for the early treatment of COVID-19
por: Vuorio, Alpo, et al.
Publicado: (2023)

Inhibition of hepatic microsomal triglyceride transfer protein – a novel therapeutic option for treatment of homozygous familial hypercholesterolemia
por: Vuorio, Alpo, et al.
Publicado: (2014)

Why continued lipoprotein apheresis is vital for homozygous familial hypercholesterolemia patients with COVID-19
por: Vuorio, Alpo, et al.
Publicado: (2021)

Familial hypercholesterolemia and COVID-19: A menacing but treatable vasculopathic condition
por: Vuorio, Alpo, et al.
Publicado: (2021)

SARS-CoV-2 reinfection()
por: Romera, I., et al.
Publicado: (2021)

Reinfection and reactivation of SARS-CoV-2
por: Dowran, Razieh, et al.
Publicado: (2022)

Adding Insult to Infection
por: Susman, E
Publicado: (2002)

Reinfection With SARS-CoV-2: Implications for Vaccines
por: Cohen, Jeffrey I, et al.
Publicado: (2020)

Serological Markers of SARS-CoV-2 Reinfection
por: Siddiqui, Sameed M., et al.
Publicado: (2022)

Reinfection with SARS-CoV-2: An inconvenient truth?
por: Sonié, Pedro, et al.
Publicado: (2022)

Epidemiological assessment of SARS-CoV-2 reinfection
por: Almadhi, Marwa, et al.
Publicado: (2022)

Reinfection, recontamination and revaccination for SARS-CoV-2
por: Kullmann, Tamás, et al.
Publicado: (2022)

Psychotropic Medication-Induced Cardiovascular Disease: Adding Insult to Injury?
por: Marziliano, Nicola, et al.
Publicado: (2023)

The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection
por: Pons, Stéphanie, et al.
Publicado: (2020)

A case of SARS-CoV-2 reinfection in Ecuador
por: Prado-Vivar, Belén, et al.
Publicado: (2021)

The Importance and Challenges of Identifying SARS-CoV-2 Reinfections
por: Babiker, Ahmed, et al.
Publicado: (2021)

SARS-CoV-2 reinfection and COVID-19 severity
por: Nguyen, Nhu Ngoc, et al.
Publicado: (2022)

Determinants of reinfection with SARS-CoV-2 Omicron variant
por: Bisharat, N., et al.
Publicado: (2023)

Double insult: flu bug enhances SARS-CoV-2 infectivity
por: Su, Shan, et al.
Publicado: (2021)

Risk of SARS-CoV-2 reinfection after natural infection
por: Boyton, Rosemary J, et al.
Publicado: (2021)

A case with SARS-CoV-2 reinfection from India
por: Munivenkatappa, Ashok, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0nk7hb0jfi3v2fiom49fqr4i81